Functional Magnetic Nanoparticles for Clinical Application: Electrochemical Immunoassay of Hepatitis B Surface Antigen and α-Fetoprotein

This work reports an efficient method to quantify the Hepatitis B surface antigen and α-fetoprotein in human serum using a functional magnetic nanoparticle-assisted sandwich-type electrochemical immunoassay. The Fe ₃ O ₄ magnetic nanoparticles were first modified with carboxyl functional groups to permit stable bioconjugation to the amine groups of most biological targets. The primary antibodies were then covalently stained on the surface of the functional magnetic nanoparticles, followed by the analyte and secondary antibodies, resulting in a sandwich-type (antibody-antigen-antibody/enzyme) immune complex. The secondary antibodies were labeled with horseradish peroxidase for the catalytic oxidation of 2-aminophenol to yield electrochemically reducible molecules. The separation using an external magnetic field guaranteed fast and reliable purification and enrichment of analytes. Quantitative analysis was performed upon representative clinical targets: Hepatitis B surface antigen and α-fetoprotein in human serum. The detection limits were 0.06 ng/mL for the former and 0.5 ng/mL for the latter, which were about 10 times lower than values obtained by conventional enzyme-linked immunosorbent assays. The reported method may be adopted as a general strategy for the sensitive and selective determination of additional proteins and biological molecules.     

The analysis and application of an HBV model

A mathematical model is formulated to describe the spread of hepatitis B. The stability of equilibria and persistence of disease are analyzed. The results shows that the dynamics of the model is completely determined by the basic reproductive number ρ₀. If ρ₀ < 1, the disease-free equilibrium is globally stable. When ρ₀ > 1, the disease-free equilibrium is unstable and the disease is uniformly persistent. Furthermore, under certain conditions, it is proved that the endemic equilibrium is globally attractive. Numerical simulations are conducted to demonstrate our theoretical results. The model is applied to HBV transmission in China. The parameter values of the model are estimated based on available HBV epidemic data in China. The simulation results matches the HBV epidemic data in China approximately.     

滚环扩增型压电石英晶体传感器检测乙型肝炎病毒

通过捕获探针与纳米金膜之间的共价连接, 保证了滚环扩增(RCA)产物始终结合于金膜表面, Phi29 DNA聚合酶的高效扩增和Escherichia coli DNA链接酶的高度精确性使检测达到单碱基识别, 检测灵敏度达到10⁴ copies/mL. 实验结果表明, 与单碱基错配序列相比, RCA可明显增强检测的灵敏度. 该RCA基因传感器操作简单, 灵敏度和特异性较高, 在乙型肝炎病毒的快速检测方面具有一定的开发潜力.     

用于乙肝表面抗原检测的压电免疫传感器的研制

研制了一种用于乙肝表面抗原（ＨＢｓＡｇ）检测的新型传感器———石英压电免疫传感器。采用聚乙烯亚胺粘附和戊二醛交联法在金电极上固定抗体蛋白，对固定化过程进行了监测。ＨＢｓＡｇ含量的检测范围为１～４０ｍｇ／Ｌ。使用过的电极用０２ｍｏｌ／Ｌ乙醇胺（ｐＨ＝８）解吸，可重复使用。将此传感器用于实际血清样品的检测，与酶联免疫吸附法所得结果吻合。     

乙肝病毒聚合酶链反应扩增产物的毛细管电泳测定

本文用毛细管电泳对乙肝病毒聚合酶反应扩增产物进行了检测，并用这一方法和酶联免疫吸附实验以及ＰＣＲ与传统电泳联用的方法进行比较，探讨了用高效，快速，微量，易自动化的毛细管电泳代替传统检测方法的可能性，取得了令人满意的结果。     

Cholesterol modulating the orientation of His17 in hepatitis C virus p7 (5a) viroporin——A molecular dynamic simulation study

The cholesterol molecules interact with p7 channel between the adjoint H3 helixes, resulting in prominent conformational changes of these helical segments, which further exerts influence on the His17 residues of i + 2 monomer, leading to the residues facing towards to the lumen of the pore. Such side chain orientations of His17 are considered to be essential for the channel’s ionic selectivity and gating.     

对氟苯酚-H_2O_2-HRP体系酶联荧光免疫分析研究ⅣF~--Zr-8-羟基喹啉-5-磺酸荧光法测定人血清中乙肝表面抗原和E抗体

将Ｚｒ－８－羟基喹啉－５－磺酸荧光体系与对氟苯酚为底物的酶促反应相偶合，建立了一种测定辣根过氧化物酶（ＨＲＰ）及其标记物的新方法．测定ＨＲＰ的线性范围为０．０３１～３１ｍＵ／ｍＬ，检出限（３σ）为０．００７ｍＵ／ｍＬ．用于测定人血清中乙肝表面抗原和Ｅ抗体，结果令人满意．     

Colorimetric detection of hepatitis B virus (HBV) DNA based on DNA-templated copper nanoclusters

DNA detection plays an important role in early diagnosis of genetic disease. The conventional detection methods of DNA are based on expensive equipment, which do not meet the demands of developing countries. Thus, we developed a colorimetric method, which could be observed with naked eye and used copper nanoclusters for cost-effective. Moreover, the target of this method is the DNA in Hepatitis B virus that is one of the most popular chronic viral infections in developing countries over the past years. Our method was sensitive and the limit of detection was 12 × 10⁹ molecules. Three-base-pair mismatches target DNA was detected easily. These results revealed the favorable sensitivity and selectivity of this approach. Most importantly, our method may have potential applications in correct diagnosis of genetic disease and monitoring of gene therapy in the poverty-stricken areas.     

Synthesis and biological evaluation of 12-benzyl matrinic amide derivatives as a novel family of anti-HCV agents

A new series of 12-benzyl matrinic amide/ethanamide derivatives were synthesized from matrinine(1)and evaluated for their anti-HCV activity,taking compound 2 as the lead.SAR revealed that the introduction of a suitable substituent at the N'-end of matrinic amide might greatly enhance the potency.Among them,matrinic acid 17 and N'-substituted matrinic amides 18a-d exhibited promising potency with low micromolar EC_(50) values ranging from 1.03μmol/L to 7.54 μmol/L,and better therapeutic window with SI from 66 to 132.Moreover,compound 17 displayed an excellent PK and safety profile in vivo,demonstrating good drug-like characteristics.Thus,it has been selected for further investigation,with an advantage of decreased chances of inducing drug-resistance mutations.     

Synthesis and Antiviral Evaluation of Some 5‐N‐Arylaminomethyl‐2‐glycosylsulphanyl‐1,3,4‐oxadiazoles and Their Analogs against Hepatitis A and Herpes Simplex Viruses

N‐Arylaminomethyl‐3H‐1,3,4‐oxadiazole‐2‐thiones 2a,b were prepared from the corresponding N‐arylglycinoylhydrazides. A number of their thioglycoside derivatives 4–7a–c and S‐functionalized analogs 8–11a,b were synthesized by the reaction with different acetobromosugars and acyclic hydroxyalkylating agents. The antiviral activity of a number of the synthesized compounds against herpes simplex virus type 1 (HSV‐1) and hepatitis A virus (HAV) was evaluated. Compounds 5a and 5b showed promising results against HAV.